echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > Clin Gastroenterology H: PNPLA3 polymorphism reduces susceptibility to diabetes in patients with nonalcoholic fatty liver disease

    Clin Gastroenterology H: PNPLA3 polymorphism reduces susceptibility to diabetes in patients with nonalcoholic fatty liver disease

    • Last Update: 2022-03-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    Nonalcoholic fatty liver disease (NAFLD) is a well-known susceptibility factor for developing diabetes


     


     


    Figure: The relationship between NAFLD and DM


    The results of this study reaffirmed the association between PNPLA3 rs738409 genotype and DM risk, showing a clear difference between subjects with and without NAFLD; due to metabolic risk


     

    Original source:

    Seoil Moon.


    A PNPLA3 Polymorphism Confers Lower Susceptibility to Incident Diabetes Mellitus in Subjects With Nonalcoholic Fatty Liver Disease.


    Leave a Comment here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.